Evelo Biosciences Inc (EVLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Operating Expenses | 108,466 | 115,396 | 91,886 | 86,357 | 58,103 |
| Operating Income | -108,466 | -115,396 | -91,886 | -86,357 | -58,103 |
| Interest Expense | 4,672 | 3,612 | 2,109 | 0 | 0 |
| Other Income | -459 | -2,740 | 738 | 1,075 | 1,157 |
| Pre-tax Income | -113,597 | -121,748 | -93,257 | -85,282 | -56,946 |
| Income Tax | 930 | 428 | 409 | 190 | N/A |
| Net Income Continuous | -114,527 | -122,176 | -93,666 | -85,472 | -56,946 |
| Net Income | $-114,527 | $-122,176 | $-93,666 | $-85,472 | $-56,946 |
| EPS Basic Total Ops | -26.20 | -46.20 | -47.40 | -53.40 | -55.60 |
| EPS Basic Continuous Ops | -26.28 | -46.18 | -47.45 | -53.37 | -52.07 |
| EPS Diluted Total Ops | -26.20 | -46.20 | -47.40 | -53.40 | -55.60 |
| EPS Diluted Continuous Ops | -26.28 | -46.18 | -47.45 | -53.37 | -52.07 |
| EPS Diluted Before Non-Recurring Items | -26.20 | -45.00 | -47.40 | -53.40 | -55.60 |
| EBITDA(a) | $-106,406 | $-113,180 | $-89,860 | $-84,757 | $-56,168 |